Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-05-06

Clinical Trial Update: The Effects of Psilocybin on Self-Focus and Self-Related Processing in Major Depressive Disorder [Phase 3]

View source ↗

Summary

Phase 3 clinical trial evaluating the effects of psilocybin on self-focus and self-related processing in Major Depressive Disorder; currently recruiting.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Psilocybin (psilocybin)

Snippet

Sponsor: Sharmin Ghaznavi | Conditions: Major Depressive Disorder | Phase 3 | Status: RECRUITING